General Anesthetic Med Chem (Exam 2 Cut Off) Flashcards
1
Q
Sedatives
A
- Drugs which decrease activity, moderate excitement, and calm recipient
- Produce state of sedation without sleep
2
Q
Hypnotics
A
- Drugs that produce drowsiness and facilitate onset/maintenance of sleep
- Resembles natural sleep in EEG and recipient can be easily aroused
3
Q
Anesthesia Spectrum
A
- No strict line between sedation, hypnotic, and anesthesia
- Increasing depths of a continuing spectrum of CNS depression
- Most drugs can produce general anesthesia at higher doses
- Widespread CNS depression is why they are often used as AED, muscle relaxants, antianxiety, and adjuncts to anesthesia
4
Q
Choral Hydrate
A
- From late 1800s
- Active form: trichloroethanol
- Disagreeable taste and irritants
- Prodrugs helped reduce these negatives (EX: triclofos)
5
Q
Barbiturates
A
- Barbital and phenobarbital were introduced in early 1900s
- As a group, barbiturates dominated the sedative/hypnotic market into the mid 1900s
- MUST BE: weakly acidic and posses a lipid-water partition coefficient within certain limits
6
Q
Barb Acidity
A
- Generally contributed to lactam-lactim and keto-enol tautomerism
- In 5,5-disubstituted barbs, only lactam-lactim is possible and these compounds have mildly acidic properties
- Becoming tri or tetra substituted doesn’t change or abolishes activity respectively
7
Q
Barbs Lipophilicity
A
- Important for CNS activity
- Want the total number of carbons on C5 to be between 6-10
- Further additions diminishes hypnotic activity
8
Q
Barb + Sulfur
A
- Replacement of oxygen at C2 with sulfur increases lipid solubility
- Creates quick onset and short duration
- Replacing more with sulfurs decreases the hypnotic activity
9
Q
Barbs + Metabolism
A
- Long acting generally used as anticonvulsants and sedatives
- Short-intermediate usually used as hypnotics
- Ultra-short usually used as IV anesthetics
- Durations of actions tend to be determined by relative rates of metabolism for barbs (excluding ultra-short)
10
Q
Aliphatic Oxidation
A
- Barb metabolism pathway
- w-1 hydroxylation at C5 if the chain has 4-5 carbons
- Faster for compounds with longer chains
- Can be hindered at w-1 site if branching occurs there
11
Q
Aromatic Oxidation
A
- Barb metabolism pathway
- Phenobarbital undergoes hydroxylation at para position on phenyl ring
- Very slow process compared to aliphatic (1/2 life ~100 hours)
12
Q
Barb SAR Summary
A
- Maximal activity: 6-10 carbons on C5
- Two groups are necessary on C5
- Substitution at N1 and N3 destroys activity (no salts)
- Sulfur on C2 yields quick onset and short duration (more = decreased activity)
13
Q
Benzo Spectrum
A
- Possess a wide spectrum of therapeutic utility
- Muscle relaxants, anesthesia induction agents, antianxiety, AED, sedative/hyponotic
14
Q
Benzos + Sedative/Hypnotics
A
- Can’t be solely a hypnotic agent based on pharmacological props
- Still primarily promoted as sleep inducers
- Based on speed on onset and duration of action
15
Q
Benzo SE
A
- Light headedness, confusion, dry mouth
- Impairment of locomotor and some mental functions
- Drug interactions relatively infrequent
- Low rate of abuse and dependence
16
Q
Zolpidem
A
- Imidazopyridine
- Chemically unrelated to benzos and barb, but interacts with GABA-A receptor complex a shares from pharmacologic properties with benzos
- Interacts more selectively with GABA-benzo receptor subtypes than benzos themselves
17
Q
Antihistamines
A
- Sometimes used as sedative/hypnotics
- Tend to be principal SE
- In some drugs, this effect has been exploited as desired therapeutic effect (Benadryl, doxylamine)
18
Q
Phenothiazines
A
- Sometimes used as a sedative/hypnotic
- Drowsiness is well known SE
- Propiomazine (used before labor) and Promethazine both known for sedative/hypnotic effects
19
Q
Anxiety
A
- Emotional state characterized by disquietude of mind and fearful anticipation of events
- Varying levels of anxiety recognized by intensity, pervasiveness, persistence, interference, and rationale
20
Q
Historical Antianxiety
A
- Barbs were first introduced for anxiety but there was concern over the tolerance, dependence, and overdose associated with them
- Propranediol carbamates (meprobamate) initially were then accepted but then found to have more undesirable properties like barbas
- Chlordiazpoxide (benzo) was then revolutionary for anxiety and at one point accounted for 75% of all antianxiety prescriptions
21
Q
Benzo Structure
A
- R1: alkyl subs are common but not necessary
- R2: Aryl or cyclohexanyl subs are important at this position (electron withdrawing group enhances potency)
- R3: Electron withdrawing group enhances potency
22
Q
Benzo MoA
A
- All effects result from actions on CNS
- Most prominently sedation, hypnosis, muscle relaxation, anticonvulsion, and decreased anxiety
- Stimulate GABA which acts as a major inhibitory neurotransmitter in the brain
23
Q
5HT1A Anti-Anxiety
A
- Buspirone is first in azaspirodecanediones
- Unrelated to benzos
- No AED/muscle relaxing properties and only mild sedation
- Main effects are agonist activity on 5HT1A receptors
- Metabolized by hydroxyolation and N-dealkylation to active metabolism
- 1-PP (active metabolite interacts and concentrates in the brain)
- Low abuse potential and doesn’t cause withdrawal effects
24
Q
Benzos + Old/Liver Problems
A
- Metabolism is markedly slower in elderly patients with hepatic dysfunction
- Agents like oxazepam then preferred since it is directy conjugated for hepatic issues
- Triazolam has relative short duration and less hangover effects for elderly patients